AN2 Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BML CAPITAL MANAGEMENT, LLC | 05/07/2025 | 5.75 M | $7.82 M | 0.00% | 19.13% |
| ALMITAS CAPITAL LLC | 05/15/2025 | 1.31 M | $1.79 B | 0.00% | 4.37% |
| VANGUARD GROUP INC | 05/09/2025 | 1.04 M | $1.41 M | 0.00% | 3.45% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2025 | 1.00 M | $1.36 M | 219.88% | 3.33% |
| PFIZER INC | 05/13/2025 | 715.30 K | $972.80 M | 0.00% | 2.38% |
| 04/30/2025 | 580.85 K | $789.96 K | 0.35% | 1.93% | |
| BANK OF NOVA SCOTIA | 05/09/2025 | 459.19 K | $624.50 K | 16.29% | 1.53% |
| TWO SIGMA ADVISERS, LP | 05/15/2025 | 445.00 K | $605.21 K | -15.77% | 1.48% |
| BANK OF MONTREAL /CAN/ | 05/13/2025 | 422.08 K | $574.03 K | 0.00% | 1.40% |
| ALDEBARAN CAPITAL, LLC | 05/13/2025 | 406.62 K | $553.01 K | 18.31% | 1.35% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 385.48 K | $524.26 K | 0.00% | 1.28% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 368.71 K | $501.44 K | -36.40% | 1.23% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2025 | 343.96 K | $467.79 K | -14.08% | 1.14% |
| BLACKROCK, INC. | 05/02/2025 | 300.69 K | $408.93 K | -0.24% | 1.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 253.92 K | $345.42 K | 11.47% | 0.84% |
| UBS GROUP AG | 05/13/2025 | 106.02 K | $144.19 K | -37.74% | 0.35% |
| STATE STREET CORP | 05/15/2025 | 87.00 K | $118.32 K | 0.00% | 0.29% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 05/15/2025 | 59.90 K | $81.46 K | -63.07% | 0.20% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 50.04 K | $68.05 K | -76.10% | 0.17% |
| 05/14/2025 | 50.00 K | $68.00 K | 100.00% | 0.17% | |
| NORTHERN TRUST CORP | 05/13/2025 | 43.20 K | $58.75 K | 0.00% | 0.14% |
| INTEGRATED WEALTH CONCEPTS LLC | 05/15/2025 | 25.00 K | $34.00 K | 0.00% | 0.08% |
| LEPERCQ DE NEUFLIZE ASSET MANAGEMENT LLC | 05/13/2025 | 23.23 K | $31.60 K | 100.00% | 0.08% |
| PRIVATE ADVISOR GROUP, LLC | 05/05/2025 | 22.50 K | $30.60 K | 0.00% | 0.07% |
| SCHONFELD STRATEGIC ADVISORS LLC | 05/15/2025 | 20.12 K | $27.36 K | -25.22% | 0.07% |
| INSPIRION WEALTH ADVISORS, LLC | 04/09/2025 | 18.95 K | $25.77 K | 100.00% | 0.06% |
| JANE STREET GROUP, LLC | 05/19/2025 | 18.13 K | $24.66 K | 100.00% | 0.06% |
| FEDERATED HERMES, INC. | 05/08/2025 | 12.24 K | $16.64 K | 63.33% | 0.04% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2025 | 10.18 K | $13.85 K | -0.01% | 0.03% |
| CAPTRUST FINANCIAL ADVISORS | 05/15/2025 | 10.00 K | $13.60 K | -65.12% | 0.03% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 2.08 K | $2.83 K | 42.31% | 0.01% |
| COLDSTREAM CAPITAL MANAGEMENT INC | 05/13/2025 | 783 | $1.07 K | 100.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 05/14/2025 | 312 | $424 | 0.00% | 0.00% |
| MORGAN STANLEY | 05/15/2025 | 300 | $408 | 0.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 05/12/2025 | 300 | $408 | 0.00% | 0.00% |
| 05/02/2025 | 200 | $272 | 0.00% | 0.00% | |
| JPMORGAN CHASE & CO | 05/12/2025 | 49 | $67 | -5.77% | 0.00% |
| MARQUETTE ASSET MANAGEMENT, LLC | 04/09/2025 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 05/14/2025 | 0 | $0 | -100.00% | 0.00% |
| SQUAREPOINT OPS LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| XTX TOPCO LTD | 05/08/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
AN2 Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 43 institutional investors and hedge funds held shares of AN2 Therapeutics, Inc.. The most heavily invested institutionals were:
BML Capital Management, LLC: 5.75 M
Almitas Capital LLC: 1.31 M
VANGUARD GROUP INC: 1.04 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 1,000,000
PFIZER INC: 715,295
BANK OF NOVA SCOTIA: 459,194
47.72% of AN2 Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 14.04 M shares in the last 24 months. This purchase volume represents approximately $15.59 M in transactions.